Inspira Technologies Oxy BHN Ltd (IINN) - Total Assets
Based on the latest financial reports, Inspira Technologies Oxy BHN Ltd (IINN) holds total assets worth $4.45 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Inspira Technologies Oxy BHN Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Inspira Technologies Oxy BHN Ltd - Total Assets Trend (2018–2024)
This chart illustrates how Inspira Technologies Oxy BHN Ltd's total assets have evolved over time, based on quarterly financial data. Check IINN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Inspira Technologies Oxy BHN Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Inspira Technologies Oxy BHN Ltd's total assets of $4.45 Million consist of 84.4% current assets and 15.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 63.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $444.00K | 5.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Inspira Technologies Oxy BHN Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Inspira Technologies Oxy BHN Ltd (IINN) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inspira Technologies Oxy BHN Ltd's current assets represent 84.4% of total assets in 2024, a decrease from 100.0% in 2018.
- Cash Position: Cash and equivalents constituted 63.3% of total assets in 2024, down from 72.7% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is inventory at 5.5% of total assets.
Inspira Technologies Oxy BHN Ltd Competitors by Total Assets
Key competitors of Inspira Technologies Oxy BHN Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Inspira Technologies Oxy BHN Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.15 | 2.61 | 0.72 |
| Quick Ratio | 0.90 | 2.61 | 0.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $429.00K | $4.81 Million | $-66.75K |
Inspira Technologies Oxy BHN Ltd - Advanced Valuation Insights
This section examines the relationship between Inspira Technologies Oxy BHN Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 20.32 |
| Latest Market Cap to Assets Ratio | 3.22 |
| Asset Growth Rate (YoY) | -13.3% |
| Total Assets | $8.07 Million |
| Market Capitalization | $25.96 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Inspira Technologies Oxy BHN Ltd's assets at a significant premium (3.22x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Inspira Technologies Oxy BHN Ltd's assets decreased by 13.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Inspira Technologies Oxy BHN Ltd (2018–2024)
The table below shows the annual total assets of Inspira Technologies Oxy BHN Ltd from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $8.07 Million | -13.32% |
| 2023-12-31 | $9.31 Million | -41.86% |
| 2022-12-31 | $16.01 Million | -38.11% |
| 2021-12-31 | $25.87 Million | +2521.07% |
| 2020-12-31 | $987.00K | +163.90% |
| 2019-12-31 | $374.00K | +3300.00% |
| 2018-12-31 | $11.00K | -- |
About Inspira Technologies Oxy BHN Ltd
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as In… Read more